Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma
Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer
Micafungin Bests Fluconazole In Phase III Antifungal Trial
Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients
Navelbine+Herceptin: 78% Response In Breast Cancer
Substance From Sea Squirts In Phase II For Breast Cancer
Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds
More Surgical Patients Die When Nurse Caseloads Rise
Neural Stem Cells Track, Treat, Brain Tumors In Mice
Cancer Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC
